Gossamer Bio, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GOSS | GANX | RNTX | HBP.TO | GTBP | ACTI.ST | |
|---|---|---|---|---|---|---|
| Market cap | 60.86M | 48.44M | 56.82M | 70.27M | 9.98M | 102.54M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.6 | -1.6 | — | -8.4 | -0.4 | — |
| Price/book | -0.6 | 4.3 | 5.5 | 4.8 | 2.4 | 2.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −94.62% | −37.50% | −57.99% | −54.68% | −65.44% | −34.67% |
| Today | +7.22% | −3.48% | −1.32% | 0.00% | −8.16% | +5.71% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GOSS news ›Gossamer Bio (NASDAQ:GOSS) Stock Rating Reaffirmed as “Buy” by Chardan Capital
Gossamer Bio (NASDAQ:GOSS – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Chardan Capital in a report released on Monday, Benzinga reports. Other equities research analysts have also recently issued…
Gossamer Bio, Inc. (GOSS) – What Are Analysts Thinking About This Stock?
Posted by Michael Walen on Oct 22nd, 2026 Get Our Latest Research Report on GOSS Shares of NASDAQ:GOSS opened at $9.79 on Thursday. The stock’s 50-day moving average is $11.62 and its 200-day moving average is $16.43. Gossamer Bio has a…
Gossamer Bio Appoints Greg Ciongoli to Board of Directors
SAN DIEGO--(BUSINESS WIRE)--$GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and…
Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash?
Gossamer Bio Inc. (GOSS) on Monday released topline findings from its late-stage PROSERA trial evaluating seralutinib in patients with pulmonary arterial hypertension (PAH), offering a mixed picture as the company weighs its regulatory…
Gossamer Bio: D. E. Shaw reports votes on 369,459 shares
Sold shares count toward October meeting voting power at Gossamer Bio (GOSS). Stock Titan - [SCHEDULE 13D/A] Gossamer Bio, Inc. Amended Major Shareholder Report Gossamer Bio: D. E. Shaw reports votes on 369,459 shares Reported voting power…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com6
- natlawreview.com1
- stocktitan.net1
- stocktwits.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.